Dean Investment Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.85M | Sell |
31,977
-1,893
| -6% | -$219K | 0.54% | 98 |
|
|
2025
Q4 | $3.57M | Sell |
33,870
-1,582
| -4% | -$149K | 0.51% | 97 |
|
|
2025
Q3 | $2.98M | Sell |
35,452
-673
| -2% | -$55.4K | 0.42% | 123 |
|
|
2025
Q2 | $2.86M | Buy |
36,125
+579
| +2% | +$46K | 0.42% | 122 |
|
|
2025
Q1 | $3.19M | Sell |
35,546
-3,530
| -9% | -$330K | 0.47% | 90 |
|
|
2024
Q4 | $3.89M | Sell |
39,076
-492
| -1% | -$50.7K | 0.55% | 60 |
|
|
2024
Q3 | $4.49M | Sell |
39,568
-1,228
| -3% | -$146K | 0.61% | 49 |
|
|
2024
Q2 | $5.05M | Sell |
40,796
-958
| -2% | -$123K | 0.72% | 40 |
|
|
2024
Q1 | $5.51M | Sell |
41,754
-132
| -0.3% | -$16.3K | 0.76% | 35 |
|
|
2023
Q4 | $4.57M | Sell |
41,886
-574
| -1% | -$59.6K | 0.65% | 56 |
|
|
2023
Q3 | $4.37M | Sell |
42,460
-110
| -0.3% | -$11.9K | 0.72% | 46 |
|
|
2023
Q2 | $4.91M | Buy |
42,570
+440
| +1% | +$50K | 0.8% | 37 |
|
|
2023
Q1 | $4.48M | Sell |
42,130
-9,958
| -19% | -$1.08M | 0.72% | 47 |
|
|
2022
Q4 | $5.78M | Buy |
52,088
+9,969
| +24% | +$1.02M | 0.98% | 19 |
|
|
2022
Q3 | $3.63M | Buy |
42,119
+6,181
| +17% | +$552K | 0.74% | 41 |
|
|
2022
Q2 | $3.28M | Buy |
35,938
+210
| +0.6% | +$18.6K | 0.64% | 51 |
|
|
2022
Q1 | $2.93M | Buy |
35,728
+325
| +0.9% | +$25.6K | 0.53% | 73 |
|
|
2021
Q4 | $2.71M | Buy |
35,403
+326
| +0.9% | +$26K | 0.48% | 81 |
|
|
2021
Q3 | $2.63M | Buy |
35,077
+896
| +3% | +$68.1K | 0.5% | 76 |
|
|
2021
Q2 | $2.66M | Sell |
34,181
-607
| -2% | -$45.1K | 0.49% | 71 |
|
|
2021
Q1 | $2.56M | Buy |
+34,788
| New | +$2.57M | 0.48% | 77 |
|
|
2019
Q1 | – | Sell |
-21,957
| Closed | -$1.6M | – | 218 |
|
|
2018
Q4 | $1.6M | Buy |
21,957
+3,144
| +17% | +$222K | 0.25% | 129 |
|
|
2018
Q3 | $1.27M | Sell |
18,813
-8,514
| -31% | -$542K | 0.18% | 140 |
|
|
2018
Q2 | $1.58M | Sell |
27,327
-405
| -1% | -$22.8K | 0.23% | 133 |
|
|
2018
Q1 | $1.44M | Buy |
27,732
+361
| +1% | +$19.5K | 0.21% | 134 |
|
|
2017
Q4 | $1.47M | Buy |
+27,371
| New | +$1.52M | 0.22% | 141 |
|
|
2014
Q1 | – | Sell |
-9,640
| Closed | -$460K | – | 232 |
|
|
2013
Q4 | $460K | Buy |
9,640
+635
| +7% | +$29K | 0.11% | 172 |
|
|
2013
Q3 | $409K | Buy |
9,005
+974
| +12% | +$44.5K | 0.11% | 173 |
|
|
2013
Q2 | $356K | Buy |
+8,031
| New | +$359K | 0.1% | 180 |
|
Other funds holding MRK
VCM
VPM
Dean Investment Associates's MRK Position: Q1 2026 in Review
Dean Investment Associates reduced its Merck (MRK) stake by 5.6% in Q1 2026, selling an estimated $219K and leaving 31,977 shares worth $3.85M. The position accounts for 0.54% of the portfolio, ranked #98.
Dean Investment Associates first reported a position in MRK in Q2 2013 and has held it in 29 quarters since. The position peaked at $5.78M in Q4 2022. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Dean Investment Associates held 31,977 shares of Merck worth $3.85M as of Q1 2026.
- Dean Investment Associates sold 1,893 Merck shares in Q1 2026, an estimated $219K.
- Merck made up 0.54% of Dean Investment Associates's portfolio in Q1 2026, its #98 holding.
- Dean Investment Associates first reported a position in Merck in Q2 2013 and has held it in 29 quarters since.
- Dean Investment Associates's Merck position peaked at $5.78M in Q4 2022.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Dean Investment Associates's 13F filing for Q1 2026, filed 15 May 2026.